Graph neural networks (GNNs) have been effectively implemented in a variety of real-world applications, while their underlying work mechanisms remain a mystery. To unveil this mystery and advocate trustworthy decision-making, many GNN explainers have been proposed. However, existing explainers often face significant challenges, such as: 1) explanations being tied to specific instances; 2) limited generalizability to unseen graphs; 3) potential generation of invalid graph structures; and 4) restrictions to particular tasks (e.g., node classification, graph classification). To address these challenges, we propose a novel explainer, GAN-GNNExplainer, which employs a generator to produce explanations and a discriminator to oversee the generation process, enhancing the reliability of the outputs. Despite its advantages, GAN-GNNExplainer still struggles with generating faithful explanations and underperforms on real-world datasets. To overcome these shortcomings, we introduce ACGAN-GNNExplainer, an improved approach that improves upon GAN-GNNExplainer by using a more robust discriminator that consistently monitors the generation process, thereby producing explanations that are both reliable and faithful. Extensive experiments on both synthetic and real-world graph datasets demonstrate the superiority of our proposed methods over existing GNN explainers.

Dementia is a group of detrimental diseases and conditions that damage the human brain and impair mental functioning. In recent years, significant efforts have been made to develop robust computer-aided diagnostic tools, particularly AI models for detection. However, their clinical implementation remains limited. One issue identified is that despite achieving high accuracy, AI-powered predictions have relied on single features or small sets of features in limited categories, hindering their robustness and generalizability. Moreover, the accuracy alone has not been sufficient to convince medical practitioners to adopt these tools, as they require transparent and scientifically grounded diagnostic processes. This study aims to improve the transparency and reliability of AI models in predicting dementia through three key steps: 1) compare a Machine Learning (ML) model's accuracy in detecting dementia when trained on a multi-domain dataset to when trained on subsets of features, 2) evaluate additional ML models for dementia detection using the multi-domain dataset, and 3) apply Explainable AI (XAI) to elucidate the importance of specific features in ML-based predictions, thereby enhancing transparency and interpretability. We hypothesize that utilizing multi-domain data will enhance the performance of ML models. Furthermore, XAI will demonstrate that features with high influence on the model's decisions are aligned with established indicators of dementia. This study contributes to the field by constructing lightweight predictive models that deliver highly accurate performance while enhancing transparency and interpretability, advancing toward clinically applicable AI-powered diagnosis.

Predicting heart disease is crucial for early diagnosis and intervention, significantly improving patient outcomes and reducing mortality rates. This study compares various machine learning models, including Logistic Regression, Random Forest, Gradient Boosting, XGBoost, and Long Short-Term Memory (LSTM) networks, using the Cleveland Heart Disease dataset. Comprehensive preprocessing steps were undertaken, such as handling missing values, converting categorical variables to numeric forms, and binarizing the target variable for binary classification. Each model was rigorously evaluated using performance metrics, including accuracy, precision, recall, F1-score, and the area under the receiver operating characteristic curve (AUC-ROC). SHapley Additive exPlanations (SHAP) values were employed to provide insights into feature importance, ensuring model transparency and interpretability. The results indicate that XGBoost outperformed all other models, achieving an accuracy of 90% and an AUC-ROC of 0.94, demonstrating its superior ability to capture complex patterns in the data through advanced optimization techniques and regularization. This study highlights the significant potential of advanced machine learning techniques, particularly ensemble methods like Gradient Boosting and XGBoost, in enhancing heart disease prediction. These models offer higher accuracy and valuable interpretability, making them practical tools for early diagnosis in clinical settings. Future research should focus on integrating these models into healthcare systems and exploring hybrid approaches to further improve predictive performance and clinical applicability.

Recently, methods to detect DoS and spoofing attacks that occur on in-vehicle networks using CAN Protocol are being studied through deep learning models such as CNN, RNN, and LSTM. These studies have produced significant results in the field of In-Vehicle Network attack detection using deep learning models. In addition, significant results are being achieved through research on applying time series-based deep learning models such as LSTM to detect DoS attacks and replay attacks occurring in in-drone networks by expanding them to drones using the UAVCAN protocol. In this paper, we conducted an experiment to detect in-drone network attacks through non-time series analysis using machine learning models and deep learning models, and through appropriate learning for each attack type, it can also be analyzed through non-time series analysis. The results showed that it was possible to detect attacks.

Stroke constitutes a significant public health concern due to its impact on mortality and morbidity. This study investigates the utility of machine learning algorithms in predicting stroke and identifying key risk factors using data from the Suita study, comprising 7,389 participants and 53 variables. Initially, unsupervised K-prototype clustering categorized participants into risk clusters, while five supervised models including Logistic Regression (LR), Random Forest (RF), Support Vector Machine (SVM), eXtreme Gradient Boosting (XGBoost), and Light Gradient Boosted Machine (Light-GBM) were employed to predict stroke outcomes. Stroke incidence disparities among identified risk clusters using the unsupervised K-prototype clustering method are substantial, according to the findings. Supervised learning, particularly RF was a preferable option because of the higher levels of performance metrics. The Shapley Additive Explanations (SHAP) method identified age, systolic blood pressure, hypertension, estimated glomerular filtration rate, metabolic syndrome, and blood glucose level as key predictors of stroke, aligning with findings from the unsupervised clustering approach in high-risk groups. Additionally, previously unidentified risk factors such as elbow joint thickness, fructosamine, hemoglobin, and calcium level demonstrate potential for stroke prediction. In conclusion, machine learning facilitated accurate stroke risk predictions and highlighted potential biomarkers, offering a data-driven framework for risk assessment and biomarker discovery.